E679 | This Week in European Tech with Dan, Mads & Lomax

The episode opened with Lomax breaking down OpenAI’s new health‑specific ChatGPT, a version that promises end‑to‑end encryption for personal health data and direct integration with Apple Health, Android Health and wearable devices. While the service is not yet available in Europe, the hosts argued that the real shift comes from the FDA’s recent announcement to streamline AI‑driven medical device approvals, effectively removing the costly, multi‑million‑dollar hurdle that has protected many startups. This regulatory easing could accelerate time‑to‑market for U.S. health‑tech firms and pressure European companies, which have traditionally relied on the FDA’s rigorous pathway to access the world’s largest healthcare market.

The conversation then turned to geopolitics, focusing on former President Trump’s renewed interest in acquiring Greenland and the broader implications for NATO and European defense budgets. Denmark’s historic 1951 defense agreement grants the United States a permanent military presence at Thule, but Greenlandic public opinion remains overwhelmingly against U.S. ownership. Hosts highlighted that the U.S. sees Greenland’s strategic location and mineral wealth as vital for its Arctic strategy, while European leaders worry about sovereignty erosion and the need to boost their own defense spending to counter perceived American overreach.

Finally, the panel examined Europe’s tightening tech regulations, citing France’s plan to ban social media for users under 15 and restrict mobile phones in schools, echoing similar moves in Norway and Denmark. These policies reflect growing concerns over digital wellbeing and a desire to assert regulatory independence from the United States, especially as the U.S. pushes for looser AI rules. The hosts concluded that the divergent regulatory approaches could deepen the transatlantic tech divide, forcing European startups to navigate a more fragmented market while seeking opportunities in the rapidly evolving AI and health sectors.